Literature DB >> 12912684

Risk factors for various causes of failure in initial corneal grafts.

Marianne O Price1, Robert W Thompson, Francis W Price.   

Abstract

OBJECTIVE: To determine the risk factors for specific causes of initial corneal graft failure.
METHODS: This study analyzed corneal graft survival rates in a longitudinal noncomparative case series of 3992 consecutive penetrating keratoplasties performed at a single large referral center. Regrafts (n = 352) were excluded from the analysis of risk factors for initial graft failure. Data were collected retrospectively from August 1, 1982, through December 31, 1986, and prospectively from January 1, 1987, through August 31, 1996. Patients were examined preoperatively, at 1, 3, 6, 9, 12, 18, and 24 months posttransplantation, and annually thereafter. Potential risk factors were evaluated individually by Kaplan-Meier survival analysis. Cox proportional hazards regression modeling was then used to investigate the impact of each independent variable, adjusted for the confounding influence of the other independent variables.
RESULTS: The use of topical glaucoma medications was a significant risk factor for corneal graft failure by 3 major causes: rejection, endothelial decompensation without a documented immunologic reaction, and ocular surface disease. Deep stromal vascularization was an independent risk factor for rejection failure. Diabetes mellitus, peripheral anterior synechiae, recipient race, and small trephination size were significant risk factors for endothelial failure.
CONCLUSION: Independent risk factors differentially impact specific causes of corneal graft failure.

Entities:  

Mesh:

Year:  2003        PMID: 12912684     DOI: 10.1001/archopht.121.8.1087

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  41 in total

1.  A Two-Piece Microkeratome-Assisted Mushroom Keratoplasty Improves the Outcomes and Survival of Grafts Performed in Eyes with Diseased Stroma and Healthy Endothelium (An American Ophthalmological Society Thesis).

Authors:  Massimo Busin; Silvana Madi; Vincenzo Scorcia; Paolo Santorum; Yoav Nahum
Journal:  Trans Am Ophthalmol Soc       Date:  2015

2.  Machine learning for segmenting cells in corneal endothelium images.

Authors:  Chaitanya Kolluru; Beth A Benetz; Naomi Joseph; Harry J Menegay; Jonathan H Lass; David Wilson
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2019-03-13

Review 3.  Graft failure: I. Endothelial cell loss.

Authors:  Ilse Claerhout; Hilde Beele; Philippe Kestelyn
Journal:  Int Ophthalmol       Date:  2008-06       Impact factor: 2.031

Review 4.  Adult keratoplasty: has the prognosis improved in the last 25 years?

Authors:  Francis W Price; Marianne O Price
Journal:  Int Ophthalmol       Date:  2008-06       Impact factor: 2.031

5.  Corneal graft rejection in African Americans at Howard University Hospital.

Authors:  Larry Ferdinand; Vanessa Ngakeng; Robert A Copeland
Journal:  Saudi J Ophthalmol       Date:  2011-04-30

6.  The effect of donor diabetes history on graft failure and endothelial cell density 10 years after penetrating keratoplasty.

Authors:  Jonathan H Lass; Tonya D Riddlesworth; Robin L Gal; Craig Kollman; Beth A Benetz; Francis W Price; Alan Sugar; Mark A Terry; Mark Soper; Roy W Beck
Journal:  Ophthalmology       Date:  2014-11-15       Impact factor: 12.079

7.  Corneal graft rejection 10 years after penetrating keratoplasty in the cornea donor study.

Authors:  Steven P Dunn; Robin L Gal; Craig Kollman; Dan Raghinaru; Mariya Dontchev; Christopher L Blanton; Edward J Holland; Jonathan H Lass; Kenneth R Kenyon; Mark J Mannis; Shahzad I Mian; Christopher J Rapuano; Walter J Stark; Roy W Beck
Journal:  Cornea       Date:  2014-10       Impact factor: 2.651

8.  Donor, Recipient, and Operative Factors Associated with Graft Success in the Cornea Preservation Time Study.

Authors:  Mark A Terry; Anthony J Aldave; Loretta B Szczotka-Flynn; Wendi Liang; Allison R Ayala; Maureen G Maguire; Christopher Croasdale; Yassine J Daoud; Steven P Dunn; Caroline K Hoover; Marian S Macsai; Thomas F Mauger; Sudeep Pramanik; George O D Rosenwasser; Jennifer Rose-Nussbaumer; R Doyle Stulting; Alan Sugar; Elmer Y Tu; David D Verdier; Sonia H Yoo; Jonathan H Lass
Journal:  Ophthalmology       Date:  2018-08-09       Impact factor: 12.079

9.  The artemisinin derivative artesunate inhibits corneal neovascularization by inducing ROS-dependent apoptosis in vascular endothelial cells.

Authors:  Rui Cheng; Cen Li; Chaoyang Li; Ling Wei; Lei Li; Yang Zhang; Yachao Yao; Xiaoqiong Gu; Weibin Cai; Zhonghan Yang; Jianxing Ma; Xia Yang; Guoquan Gao
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-05-15       Impact factor: 4.799

10.  Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response.

Authors:  Anna I Markowska; Fu-Tong Liu; Noorjahan Panjwani
Journal:  J Exp Med       Date:  2010-08-16       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.